Video

What Is The GS Discovery® Transient Expression System?

Source: Lonza

Transient gene expression can offer a fast path to material generation in early biotherapeutic development, but achieving both speed and high titers is a challenge. In this video, Peter O'Callaghan, Senior Director and Head of Expression System Sciences, Licensing, explores Lonza's GS Discovery® transient expression platform and the technologies designed to improve its performance and consistency.

The discussion covers two approaches within the platform: a standard chemical transfection process that generates material in roughly 8–10 days, and a novel GS piggyBac®-powered process built to prioritize higher titers.

O'Callaghan also explains how the platform uses the same host cells, expression vectors, and transposase technology as Lonza's broader GS Gene Expression System® platform, creating consistency in product quality between transient and stable expression workflows. This supports a more streamlined path from early material generation through stable pool and clonal cell line development.

Watch the full video to learn how GS Discovery® combines ease of use, rapid timelines, high-titer potential, and platform consistency to support biotherapeutic development.

Access The Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online